Kenya KEMSA Direct Hospital Procurement Framework Launched

• Individual hospitals in Kenya can now directly procure medical supplies from KEMSA under a new legal framework.
• This change aims to improve timely delivery, increase flexibility, and enhance the availability of essential medicines, especially for Level 3 and 4 hospitals.
• The reforms address past issues like corruption, mismanagement, and logistical delays associated with county-level procurement, leading to up to 7% reduction in some drug costs.
• Despite a 92% KEMSA refill rate, only 51% of patients in Level 4 and lower-tier hospitals currently access necessary drugs.
• The government is promoting local manufacturing of essential medical products to boost supply, withstand global shocks, and reduce costs.

This strategic shift aims to overcome historical challenges, including alleged mismanagement by devolved units, significant debts, and persistent logistical delays that plagued the previous system.

A significant shift in Kenya's healthcare supply chain management has been implemented, allowing individual hospitals to directly procure essential medical supplies from the Kenya Medical Supplies Agency (KEMSA). This new legal framework, announced by Dr. Ouma Oluga, the Principal Secretary for Medical Services, is intended to streamline the acquisition process for health facilities across the nation. The primary objective is to guarantee the timely delivery of vital medicines and equipment, thereby enhancing patient care.

This direct procurement model grants hospitals increased autonomy and flexibility in sourcing their medical commodities, a departure from previous, often cumbersome, procedures. Dr. Oluga emphasized that these changes are poised to bolster the availability of crucial medical supplies, particularly addressing historical shortages of vital drugs and equipment that frequently affected Level 3 and Level 4 hospitals. The expectation is that this direct engagement will lead to more efficient and responsive supply lines.

The introduction of the Kenya KEMSA direct hospital procurement framework comes as a direct response to systemic issues that plagued the prior distribution model. Previously, county governments served as the primary recipients of supplies from KEMSA, a system frequently marred by allegations of mismanagement within the devolved units, substantial outstanding debts, and significant logistical delays. These challenges often resulted in critical shortages at the point of care, undermining public health efforts.

In parallel with the new procurement framework, KEMSA has undergone substantial governance reforms specifically designed to tackle past incidents of corruption and to improve the overall delivery of drugs and equipment to hospitals. These comprehensive KEMSA governance changes hospitals are experiencing are part of a broader effort to restore trust and efficiency. As a result of KEMSA's efforts to consolidate its supply chain systems, some drug costs have already seen reductions of up to 7 percent, a measure aimed at safeguarding patient care and optimizing resource allocation. This strategic shift aims to overcome historical challenges, including alleged mismanagement by devolved units, significant debts, and persistent logistical delays that plagued the previous system.

Despite the promising reforms and the expansion of KEMSA's medical supplies refill rate to an impressive 92 percent, significant disparities in patient access to drugs persist. Dr. Oluga highlighted that only about 51 percent of patients in Level 4 and lower-tier hospitals currently receive the medications they need. This gap points to ongoing challenges within the Kenya medical supply chain legislation and its implementation, indicating that while supplies may be available at KEMSA, they are not consistently reaching the end-users.

Further complicating the supply landscape are instances of collusion between pharmacists and chemists operating near hospitals, reportedly siphoning off drugs intended for public facilities. The prevalence of private chemist businesses outside major public hospitals, often targeting patients unable to obtain prescriptions from government facilities, underscores the need for continued vigilance and reform. To enhance stocking, build resilience against global supply shocks, and ultimately lower drug costs, the government is actively promoting the local manufacturing of essential medical products, a long-term strategy to secure Kenya's healthcare future.

The new KEMSA medical supplies direct sourcing Kenya model represents a pivotal moment for the nation's healthcare sector. By empowering individual hospitals to manage their procurement directly, the framework is expected to significantly mitigate the shortages of essential medicines, diagnostic equipment, and other critical medical commodities that have historically hampered healthcare delivery. This initiative is a core component of broader Kenya healthcare procurement reforms aimed at creating a more robust, transparent, and efficient system.

The Principal Secretary for Medical Services, Dr. Oluga, underscored that these reforms are fundamentally about ensuring that every patient, regardless of their location or the level of their healthcare facility, has access to the necessary medical provisions. The success of this framework will depend on consistent implementation, ongoing oversight, and the continued commitment to addressing the remaining challenges in drug access and distribution. Ultimately, these changes are designed to safeguard patient well-being and strengthen the overall capacity of Kenya's public health infrastructure.

Lawyers advising hospitals and healthcare providers in Kenya should review the new legal framework for direct procurement from KEMSA to ensure compliance with updated procedures and leverage potential efficiencies in medical supply acquisition. Compliance officers must update internal procurement policies to align with these changes and address any lingering risks from past supply chain issues.

Source: Reporting based on official statements from the Principal Secretary Medical Services.